INNOVACAP
Innova Captab Limited
Healthcare · Drug Manufacturers - Specialty & Generic
Market price data is delayed by at least 15 minutes. Not for trading or investment decisions.
Fundamentals
Current Price
₹677.6
P/B Ratio
3.8
52W High
₹1,020.7
52W Low
₹622
Dividend Yield
0.59%
Profit Margin
8.85%
ROE
—
Debt / Equity
0.33
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Peer Comparison same NSE industry · top 10 by 1M return
Finance Nbfcas of 8 Apr 2026 close
| Symbol | Company | Price | P/B | RSI | 1M Ret | ROE | D/E |
|---|---|---|---|---|---|---|---|
| INNOVACAPyou | Innova Captab Limited | ₹683.15 | 3.83 | 43.7 | +0.3% | — | 0.33 |
| VIJIFIN | Viji Finance Limited | ₹3.22 | 2.19 | 61.1 | +40.6% | — | 0.55 |
| DCMFINSERV | DCM Financial Services Limit | ₹5.38 | -0.24 | 16.8 | +37.6% | — | — |
| ACMESOLAR | Acme Solar Holdings Limited | ₹273.2 | 3.46 | 63.2 | +24.5% | — | 2.72 |
| FEDFINA | Fedbank Financial Services L | ₹141.63 | 1.95 | 61.4 | +17.2% | — | 3.83 |
| PAISALO | Paisalo Digital Limited | ₹38.24 | 2.08 | 72.5 | +15.1% | — | 2.26 |
| JAGSNPHARM | Jagsonpal Pharmaceuticals Li | ₹192.84 | 5.10 | 70.3 | +14.6% | — | 0.03 |
| TCIFINANCE | TCI Finance Limited | ₹15.13 | -0.26 | 65.0 | +10.6% | — | — |
| THEINVEST | The Investment Trust Of Indi | ₹102.66 | 0.74 | 57.9 | +9.3% | — | 0.67 |
| MOTILALOFS | Motilal Oswal Financial Serv | ₹757.4 | 3.53 | 62.8 | +9.3% | — | 1.21 |
| VHL | Vardhman Holdings Limited | ₹3,344.9 | 0.29 | 64.9 | +9.2% | — | — |
Price Chart
Quarterly Results Last 4 quarters
| Metric | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|
| Revenue | ₹450.3 Cr | ₹380.4 Cr | ₹351.5 Cr | ₹305.5 Cr |
| Gross Profit | ₹158.5 Cr | ₹136.8 Cr | ₹130.8 Cr | ₹83.5 Cr |
| Operating Income | ₹58.0 Cr | ₹40.5 Cr | ₹41.1 Cr | ₹42.0 Cr |
| Net Income | ₹42.1 Cr | ₹29.7 Cr | ₹31.0 Cr | ₹29.6 Cr |
Values in INR Crore. Source: yfinance / NSE filings.
SWOT Analysis AI · news + fundamentals
SWOT not available.
Recent News Sentiment
No recent news for this stock.
Data sourced from yfinance and public NSE filings. Not investment advice.